Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alpha.
暂无分享，去创建一个
A. Dirican | M. Akyol | Y. Yildiz | A. Alacacıoğlu | Ç. Erten | M. Tarhan | Y. Kucukzeybek | A. Can | I. V. Bayoglu | L. Demir | K. Payzin | I. Somalı | Mehmet Koeseoglu | I. Bayoglu